| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.671 | 17.177 | 34.716 | 33.814 | 25.844 | 29.472 | 22.990 | 22.887 | 29.113 | 24.372 |
| Total Income - EUR | 16.671 | 17.177 | 34.716 | 33.814 | 27.056 | 29.472 | 22.990 | 22.892 | 29.114 | 24.372 |
| Total Expenses - EUR | 11.705 | 8.029 | 16.040 | 22.695 | 24.599 | 24.327 | 20.455 | 23.217 | 24.517 | 31.141 |
| Gross Profit/Loss - EUR | 4.966 | 9.148 | 18.676 | 11.119 | 2.457 | 5.145 | 2.535 | -325 | 4.597 | -6.769 |
| Net Profit/Loss - EUR | 4.466 | 8.976 | 18.329 | 10.781 | 2.198 | 4.868 | 2.332 | -554 | 4.306 | -7.500 |
| Employees | 2 | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Elissan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 374 | 191 | 5.018 | 4.106 | 3.184 | 0 |
| Current Assets | 9.356 | 19.172 | 31.174 | 32.320 | 28.198 | 19.074 | 15.947 | 5.333 | 8.858 | 2.990 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.334 | 2.523 |
| Receivables | 8.317 | 17.694 | 29.632 | 30.888 | 24.310 | 15.701 | 13.502 | 1.757 | 4.428 | 977 |
| Cash | 1.039 | 1.478 | 1.541 | 1.432 | 3.889 | 3.374 | 2.445 | 3.575 | 2.096 | -510 |
| Shareholders Funds | 3.122 | 12.066 | 30.191 | 31.822 | 27.881 | 18.530 | 20.452 | 8.223 | 4.619 | -2.906 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.234 | 7.106 | 982 | 498 | 691 | 735 | 513 | 1.216 | 7.423 | 5.897 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Elissan Med Srl